Dyspnea, Paroxysmal: Clinical Trials

7 trials for Dyspnea, Paroxysmal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 withdrawn. 2 Not applicable, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Withdrawn 1
Phase 32Completed 2
Phase 21Completed 1

Follow Dyspnea, Paroxysmal: new trials by email Literature Review of Dyspnea, Paroxysmal trials Research Report on Dyspnea, Paroxysmal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Circuit Training With and Without Upper and Lower Limb Resistance Training in Post-CABG Patients
Circuit Training with upper and lower limb Resistance Training, Circuit Training Exercises - Dyspnea, Paroxysmal
Not applicableCompletedRiphah International University602025-07-052026-03-20
Management of Cardiogenic Pulmonary Edema (RENAU-OAP)
Baseline care, Referential's dissemination - Dyspnea, Paroxysmal, Heart Failure, Left Sided
TerminatedCentre Hospitalier Annecy Genevois8592015-01-012019-06-18
Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer Patients
Fentanyl, Immediate release morphine - Cancer, Dyspnea, Paroxysmal
Phase 2CompletedUniversity of Cologne102013-03-012020-11-19
Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload
Aquapheresis, Furosemide - Leukemia
Not applicableWithdrawnM.D. Anderson Cancer Center2013-03-012013-04-05
Heart Failure and a Preserved Ejection Fraction
O2 consumption max bike test - Heart Failure
CompletedMayo Clinic512007-04-012010-10-14
A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels
nesiritide - Heart Failure, Congestive, Heart Decompensation
Phase 3CompletedScios, Inc.3051997-01-012011-03-04
A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest
nesiritide - Heart Failure, Congestive, Heart Decompensation
Phase 3CompletedScios, Inc.1271996-10-012011-06-10

Narrower conditions

Heart Failure (4)  ·  Cardiomyopathies (2)  ·  Renal Insufficiency (2)  ·  Dyspnea (1)  ·  Edema (1)  ·  Edema, Cardiac (1)  ·  Heart Failure, Diastolic (1)  ·  Hypoxia (1)  ·  Leukemia (1)  ·  Neoplasms (1)  ·  Respiratory Sounds (1)

Broader conditions

Cardiovascular Diseases (7)  ·  Heart Diseases (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Respiration Disorders (7)  ·  Respiratory Tract Diseases (7)  ·  Signs and Symptoms (7)  ·  Signs and Symptoms, Respiratory (7)  ·  Dyspnea (6)  ·  Heart Failure (3)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)

Interventions

Natriuretic Peptide, Brain (2)  ·  Circuit-Based Exercise (1)  ·  Fentanyl (1)  ·  Furosemide (1)

Sponsors

Scios, Inc. (2)  ·  Centre Hospitalier Annecy Genevois (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Riphah International University (1)  ·  University of Cologne (1)

Countries

France (1)  ·  Germany (1)  ·  Pakistan (1)  ·  United States (1)

Top investigators

Barry A. Borlaug, MD (1)  ·  Gloria Iliescu, MD (1)  ·  Raymond Voltz, Professor (1)

Results publications

PMID 10400005, PMID 10080475, PMID 11099425, PMID 11828925, PMID 14984918, PMID 15888853, PMID 16380593, PMID 16616558, PMID 23186936, PMID 23697057